Drug Profile
Zelquistinel - Gate Neurosciences
Alternative Names: AGN-241751; GATE-251Latest Information Update: 04 Aug 2023
Price :
$50
*
At a glance
- Originator Aptinyx
- Developer AbbVie; Gate Neurosciences
- Class Amines; Antidepressants; Aza compounds; Esters; Ketones; Small molecules; Spiro compounds
- Mechanism of Action NMDA receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase II Major depressive disorder